<DOC>
	<DOCNO>NCT01696734</DOCNO>
	<brief_summary>The goal clinical research study learn domperidone help control chronic GI disorder . The safety drug also study . Domperidone design stimulate contraction stomach increase ability empty food .</brief_summary>
	<brief_title>Treatment Protocol Compassionate Use Domperidone</brief_title>
	<detailed_description>Study Drug Administration : If find eligible take part study , take domperidone tablet water 30 minute meal . You may ask take tablet bed . During study , doctor may increase amount study drug take . You need record take study drug study drug diary . This diary review clinic visit . Study Procedures : Starting 8 week first dose study drug , study visit every 2 month first year take study drug , every 6 month . During visit , follow test procedure perform : - You physical exam , include measurement vital sign . - Your medical history record . - You EKG 2 month , 6 month , 12 month first year every 6 month . If doctor think need , EKG repeat . You EKG regular doctor . - You ask drug may take side effect may . - You complete 2 questionnaire GI symptom - Blood ( 3 tablespoon ) draw routine test 2 month , 6 month , 12 month first year every follow-up visit . If doctor think need , blood test repeat . You blood draw regular doctor . Length Study : You may continue take study drug long benefitting . You longer able take study drug intolerable side effect occur unable follow study direction . Follow-Up : About 30 day last dose study drug : - You physical exam , include measurement vital sign . - Your medical history record . - You EKG . - You ask drug may take side effect may . - Blood ( 3 tablespoon ) draw routine test . If take study due result EKG , refer cardiology department test . This investigational study . Domperidone FDA approve commercially available . It currently use research purpose . Up 200 patient enrol study . All take part MD Anderson .</detailed_description>
	<mesh_term>Gastrointestinal Diseases</mesh_term>
	<mesh_term>Digestive System Diseases</mesh_term>
	<mesh_term>Domperidone</mesh_term>
	<criteria>1 . Patients GI disorder fail standard therapy . 2 . Age 16 old 3 . Symptoms manifestation : ) gastroparesis ; b ) refractory GERD include persistent esophagitis , refractory heartburn , refluxrelated laryngitis , respiratory symptom ; c ) severe dyspepsia . 4 . Completion comprehensive evaluation , include clinical history physical examination , eliminate cause symptom . 5 . Patient sign informed consent document agree use study drug , domperidone . 6 . WBC differential great 3,000/ml ; alkaline phosphatase le 1.5 x upper limit normal ; ALT le 2 x upper limit normal ; AST le 2 x upper limit normal ; bilirubin less equal 2 x upper limit normal ; BUN le 2 x upper limit normal ; creatinine le 1.5 x upper limit normal ; stable hemoglobin great equal 8.0 g/dl ; potassium range 3.0 5.5 , magnesium level 1.82.9 mg. 1 . Patients follow cardiac diagnosis : Ventricular tachycardia fibrillation ; Torsade des Pointes ; clinically significant bradycardia ; sinus node dysfunction ; heart block ; prolong QTc interval ( QTc &gt; 450 millisecond male , QTc &gt; 470 millisecond female ) ; valvular , ischemic , pulmonary heart disease ; cardiomyopathy ; history heart failure 2 . Patients receive antiarrhythmic medication action repolarization time ( prolongation QTc interval Amiodarone , Disopyramide , Dofetilide , Flecainide , Ibutilide , Quinidine , Sotalol , Dronedarone etc . ) 3 . Patients receive monoamine oxidase ( MAO ) inhibitors 4 . Patients history active liver failure 5 . Clinically significant electrolyte disorder include sodium &lt; 130 &gt; 145 and/or potassium &lt; 3.0 &gt; 5.5 /or magnesium &lt; 1.8 &gt; 2.9 . 6 . GI hemorrhage obstruction experience within previous 6 week 7 . Presence prolactinoma ( prolactinreleasing pituitary tumor ) 8 . Pregnant breastfeed female ( Women childbearing potential [ WOCBP ] , define postmenopausal 12 month without previous surgical sterilization , must negative urine pregnancy test within 30 day first administration domperidone must either commit continued abstinence heterosexual intercourse use effective method birth control course study ) 9 . Known allergy domperidone</criteria>
	<gender>All</gender>
	<minimum_age>16 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2016</verification_date>
	<keyword>Gastrointestinal disease</keyword>
	<keyword>GI</keyword>
	<keyword>Compassionate use</keyword>
	<keyword>GI motility disorder</keyword>
	<keyword>GI disorder</keyword>
	<keyword>Gastroparesis</keyword>
	<keyword>Gastroesophageal reflux disease</keyword>
	<keyword>GERD</keyword>
	<keyword>Chronic nausea vomit</keyword>
	<keyword>Questionnaires</keyword>
	<keyword>Surveys</keyword>
	<keyword>Phone call</keyword>
	<keyword>Domperidone</keyword>
</DOC>